Showing results (1-10 of 544) with videos related to

Sort By:
Pageof 55
Current Opinion in Cardiology|May 9, 2012
Lessons from platelet inhibition and patient outcomesClaes Held
Upsala Journal of Medical Sciences|November 15, 2018
When do we need clinical endpoint adjudication in clinical trials?Claes Held
Open Heart|September 1, 2025
Anticoagulation and antiplatelet strategies used in Sweden in patients with myocardial infarction and concomitant atrial fibrillation: nationwide cohort studyJulia Aulin, Angelo Modica, Lars Lindhagen, et al.
Clinical Trials (London, England)|May 20, 2021
Assessing the external validity of the VALIDATE-SWEDEHEART trialRebecca T Rylance, Philippe Wagner, Elmir Omerovic, et al.
European Heart Journal|October 15, 2013
Duration of dual antiplatelet treatment with clopidogrel and aspirin in patients with acute coronary syndromeChristoph Varenhorst, Karin Jensevik, Tomas Jernberg, et al.
European Heart Journal|January 24, 2007
Effects of revascularization within 14 days of hospital admission due to acute coronary syndrome on 1-year mortality in patients with previous coronary artery bypass graft surgeryClaes Held, Per Tornvall, Ulf Stenestrand
American Heart Journal|August 4, 2024
Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stentDavid Erlinge, Jonas Andersson, Ole Fröbert, et al.
Kidney International|November 21, 2016
Long-term versus short-term dual antiplatelet therapy was similarly associated with a lower risk of death, stroke, or infarction in patients with acute coronary syndrome regardless of underlying kidney diseaseJuan-Jesus Carrero, Christoph Varenhorst, Karin Jensevik, et al.
International Journal of Cardiology|January 8, 2017
Cognitive ability, lifestyle risk factors, and two-year survival in first myocardial infarction men: A Swedish National Registry studyJohn Wallert, Guy Madison, Claes Held, et al.
BMC Medical Informatics and Decision Making|July 7, 2017
Predicting two-year survival versus non-survival after first myocardial infarction using machine learning and Swedish national register dataJohn Wallert, Mattia Tomasoni, Guy Madison, et al.
Pageof 55